1. (1) The board shall register an applicant to manufacture or distribute dangerous drugs included in 50-32-222, 50-32-224, 50-32-226, 50-32-229, and 50-32-232 unless it determines that the issuance of that registration would be inconsistent with the public interest.

2. (2) In determining the public interest, the board shall consider the following factors:

   1. (a) maintenance of effective controls against diversion of dangerous drugs into other than legitimate medical, scientific, or industrial channels;
   2. (b) compliance with applicable state and local law;
   3. (c) any convictions of the applicant under any federal and state laws relating to any dangerous drug;
   4. (d) past experience in the manufacture or distribution of dangerous drugs and the existence in the applicant's establishment of effective controls against diversion;
   5. (e) furnishing by the applicant of false or fraudulent material in any application filed under this chapter;
   6. (f) suspension or revocation of the applicant's federal registration to manufacture, distribute, or dispense dangerous drugs as authorized by federal law; and
   7. (g) any other factors relevant to and consistent with the public health and safety.
3. (3) Compliance by manufacturers and distributors with the provisions of the federal law respecting registration (excluding fees) entitles them to be registered under this chapter.

History: En. Sec. 17, Ch. 412, L. 1973; amd. Sec. 7, Ch. 350, L. 1974; R.C.M. 1947, 54-317(1), (4).